Here are three points:
1. The INSPIRE study tests InVivo Therapeutics’ Neuro-Spinal Scaffold’s efficacy and safety for complete thoracic AIS A spinal cord injury.
2. Neurosurgeon Stuart Lee, MD, serves as the site’s director.
3. Vidant Medical Center represents one of 22 U.S. and Canadian hospitals involved in the INSPIRE study.
More articles on devices:
Medline to build new distribution center; adds 100 jobs in Florida — 6 points
3D technology makes its mark in medical device industry — 3 observations
Spine Wave launches Velocity L Expandable Interbody Device & lateral system: 5 takeaways
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
